ArticlePloS one2022
Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021).
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Epidemiology ofBMJ global health · 2026Pooled it
- Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression.PLoS medicine · 2024Pooled it
- One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis.The New England journal of medicine · 2025Trial
- Sexual knowledge as a predictor of intention in sexual activity in university women.AJOG global reports · 2026Article
- Multilevel factors associated with self-reported sexually transmitted infections among sexually active women in Africa: a socio-ecological analysis.BMC public health · 2026Article
- Distribution of Mother-to-Child Transmitted (MTCT) Infections and Socioeconomic Vulnerability Within the Gran Chaco Region.Tropical medicine and infectious disease · 2026Article
- Educational intervention with a booklet on syphilis for women in situations of sexual vulnerability: a quasi-experimental study.Revista latino-americana de enfermagem · 2026Article
- Syphilis and the Eye: Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Paradigms.Pathogens (Basel, Switzerland) · 2025Review
- The Epidemiology of Syphilis Worldwide in the Last Decade.Journal of clinical medicine · 2025Review
- Factor selection techniques based on partial least squares for classification to determine the risk factors of sexually transmitted infections.Scientific reports · 2025Article
- Article
- Increasing Access To Sexually Transmitted Infection Testing: The Promise of Point-of-Care and Over-the-Counter Tests.Current HIV/AIDS reports · 2025Review
- Tp40: a new potential prognostic and diagnostic marker for syphilis.Microbiology spectrum · 2025Article
- Global, regional, and national burden and trends of syphilis among women of childbearing age from 1990 to 2021.Frontiers in public health · 2025Article
- Determinants of delayed healthcare seeking among STI patients in Eastern Ethiopia: a case-control study.Frontiers in public health · 2025Article
- Breaking the ice - simplified freeze-fracture of parasitic protists: a cost-effective approach without highly specialised equipment.Memorias do Instituto Oswaldo Cruz · 2025Article
- WHO global research priorities for sexually transmitted infections.The Lancet. Global health · 2024Review
- Article
- Article
- Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis.BMJ global health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
backgroundIn 2016, WHO launched the Global Health Sector Strategy on STIs, 2016-2021 (GHSS) to provide guidance and benchmarks for country achievement by 2020 and four global targets for achievement by 2030.
methodsA country survey jointly developed by experienced technical personnel at WHO Headquarters (HQ) and WHO regional offices was reviewed and distributed by WHO regional advisors to 194 WHO Member States in September-March 2020. The survey sought to assess implementation and prioritization of STI policy, surveillance, service delivery, commodity availability, and surveillance based on targets of the GHSS.
resultsA majority (58%, 112/194) of countries returned a completed survey reflecting current (2019) STI activities. The regions with the highest survey completion rates were South-East Asia Region (91%, 10/11), Region of the Americas (71%, 25/35) and Western Pacific Region (67%, 18/27). Having a national STI strategy was reported by 64% (72/112) and performing STI surveillance activities by 88% (97/110) of reporting countries. Availability of STI services within primary health clinics was reported by 88% of countries (99/112); within HIV clinics by 92% (103/112), and within reproductive health services by 85% (95/112). Existence of a national strategy to eliminate mother-to-child transmission of HIV and syphilis (EMTCT) was reported by 70% of countries (78/112). Antimicrobial resistance (AMR) monitoring for gonococcal infection (gonorrhoea) was reported by 64% (57/89) of reporting countries with this laboratory capacity. Inclusion of HPV vaccine for young women in the national immunization schedule was reported by 59% (65/110) and availability of cervical cancer screening was reported by 91% (95/104). Stockouts of STI medicines, primarily benzathine penicillin, within the prior four years were reported by 34% (37/110) of countries.
conclusionsMechanisms to support improvements to STI service delivery through national-level policy, commitment, programming and surveillance are needed to operationalize, accelerate and monitor progress towards achievement of the 2030 global STI strategy targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.